CapqueSign Launches Electronic Signatures for Clinical Research

ATLANTA, GA, UNITED STATES, October 20, 2026 /CourierPR/ -- Capque Technologies LLC, powered by ClinFocus Inc., has launched CapqueSign, an electronic signature platform designed for clinical trial documents. This new tool is aimed at simplifying the regulatory compliance process for smaller sponsors, contract research organizations (CROs), and site networks, which often struggle with the extra costs and lengthy IT and procurement cycles associated with traditional signature tools.

CapqueSign supports the signing of various clinical trial documents, including protocols, protocol amendments, site agreements, and other trial documents in both PDF and Word formats. The platform is designed to meet the stringent requirements of 21 CFR Part 11, which governs electronic signatures in FDA-regulated clinical research. These requirements include signer authentication, signature manifestation, linking signatures to records, and secure audit trails.

Keke Okeke, Chief Financial Officer of Capque Technologies LLC, explained that the company's goal was to make compliance controls accessible to smaller organizations.

CapqueSign offers three pricing plans: Free, Standard, and Enterprise. The Free plan allows three envelopes per month with no credit card required. The Standard plan costs $19.99 per user per month and includes 25 envelopes per user each month, priority support, and access to the CapqueSign validation package on request. The Enterprise plan offers unlimited users and envelopes with custom pricing based on users, volume, and sites. Annual billing includes two months at no charge.

Capque Technologies validated CapqueSign for 21 CFR Part 11 and provides its validation package to Standard and Enterprise customers on request, allowing customer quality assurance teams to review the evidence directly. Each regulated organization remains responsible for confirming the system fits its intended use, consistent with its own procedures and training.

CapqueSign is now available for self-serve registration at capquesign.com. Enterprise inquiries can be submitted through the contact page on the same site.

CapqueSign is the first product released on the Capque Connected Intelligence platform. It supports signing of protocols, protocol amendments, site agreements, and other trial documents in PDF and Word formats. The platform includes the same core controls on every plan. Each signer confirms identity with multi-factor authentication before signing, and every action is recorded in a full audit trail that can be exported in one step for quality review or filing in an electronic trial master file. Senders set signing order and deadlines, and automated email notifications and reminders keep documents moving without manual follow-up.

The Free plan allows three envelopes per month with no credit card required. The Standard plan costs $19.99 per user per month and includes 25 envelopes per user each month, priority support, and access to the CapqueSign validation package on request. The Enterprise plan offers unlimited users and envelopes with custom pricing based on users, volume, and sites. Annual billing includes two months at no charge.

Capque Technologies validated CapqueSign for 21 CFR Part 11 and provides its validation package to Standard and Enterprise customers on request, so customer quality assurance teams can review the evidence directly. Each regulated organization remains responsible for confirming the system fits its intended use, consistent with its own procedures and training.

CapqueSign is available now with self-serve registration at capquesign.com. Enterprise inquiries can be submitted through the contact page on the same site.